Swiss big pharma settles patent dispute with Insulet

The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

English court says Roche did not infringe insulin pump patents

13 July 2021 The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.

Americas

Judge cuts ‘disproportionate’ £1.7m costs claim by Roche

27 July 2021 Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.

Big Pharma

Medtronic’s $738m deal with insulin maker at risk

12 October 2023 Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.

More on this story

Americas

Judge cuts ‘disproportionate’ £1.7m costs claim by Roche

Medtech

English court says Roche did not infringe insulin pump patents

13 July 2021 The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.

Big Pharma

Medtronic’s $738m deal with insulin maker at risk

More on this story

Americas

Judge cuts ‘disproportionate’ £1.7m costs claim by Roche

Medtech

English court says Roche did not infringe insulin pump patents

13 July 2021 The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.

Big Pharma

Medtronic’s $738m deal with insulin maker at risk